We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Wolf Minerals | LSE:WLFE | London | Ordinary Share | AU000000WLF3 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.40 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2020 to Jan 2025
TIDMWLFE
RNS Number : 5445T
Wolf Minerals Limited
04 July 2018
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Hot Features
Premium
Name of entity
WOLF MINERALS LIMITED
-------------------------
ABN
11 121 831 472
----------------------------
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities Fully Paid Ordinary Shares
issued or to be
issued
2 Number of +securities 795,918 Fully Paid
issued or to be Ordinary
issued (if known) Shares
or maximum number
which may be issued
3 Principal terms Fully Paid Ordinary Shares
of the +securities 795,918 ordinary shares
(e.g. if options, issued to a former employee
exercise price upon vesting of performance
and expiry date; rights issued in accordance
if partly paid with the Wolf Minerals
+securities, the Limited Performance Rights
amount outstanding Plan, as approved by
and due dates shareholders on 29 November
for payment; if 2016. One Performance
+convertible securities, Right is converted into
the conversion one fully paid ordinary
price and dates share in the Company
for conversion) for nil cash consideration.
---------------------------------------------
4 Do the +securities Fully Paid Ordinary Shares
rank equally in Yes - equally in all
all respects from respects with quoted
the +issue date securities WLF Fully
with an existing Paid Ordinary Shares
+class of quoted
+securities?
If the additional
+securities do
not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
---------------------------------------------
5 Issue price or Fully Paid Ordinary Shares
consideration Nil
---------------------------------------------
Purpose of the
issue
6 (If issued as
consideration
for the acquisition
of assets, clearly
identify those
assets)
----------------------------------------------------------------
Is the entity Yes
an +eligible entity
6a that has obtained
security holder
approval under
rule 7.1A?
If Yes, complete
sections 6b -
6h in relation
to the +securities
the subject of
this Appendix
3B, and comply
with section 6i
----------------------------------------------------------------
The date the security 28 November 2017
holder resolution
6b under rule 7.1A
was passed
----------------------------------------------------------------
Number of +securities Nil
issued without
6c security holder
approval under
rule 7.1
----------------------------------------------------------------
Number of +securities Nil
issued with security
6d holder approval
under rule 7.1A
----------------------------------------------------------------
Number of +securities Nil
issued with security
6e holder approval
under rule 7.3,
or another specific
security holder
approval (specify
date of meeting)
----------------------------------------------------------------
Number of +securities 795,918 Ordinary Shares
issued under an
6f exception in rule
7.2
----------------------------------------------------------------
If +securities N/A
issued under rule
6g 7.1A, was issue
price at least
75% of 15 day
VWAP as calculated
under rule 7.1A.3?
Include the +issue
date and both
values. Include
the source of
the VWAP calculation.
----------------------------------------------------------------
If +securities N/A
were issued under
6h rule 7.1A for
non-cash consideration,
state date on
which valuation
of consideration
was released to
ASX Market Announcements
----------------------------------------------------------------
Calculate the
entity's remaining
issue capacity
under rule 7.1
and rule 7.1A
- complete Annexure
1 and release
to ASX Market
6i Announcements 272,720,063
----------------------------------------------------------------
7 +Issue dates 3 July 2018
Note: The issue
date may be prescribed
by ASX (refer
to the definition
of issue date
in rule 19.12).
For example, the
issue date for
a pro rata entitlement
issue must comply
with the applicable
timetable in Appendix
7A.
Cross reference:
item 33 of Appendix
3B.
Number +Class
------------------------------------------- -------------------
Number and +class
of all +securities
quoted on ASX
(including the
+securities in Fully Paid
8 section 2 if applicable) 1,090,880,251 Ordinary Shares
------------------------------------------- -------------------
Number +Class
----------- --------------------
Number and +class
of all +securities
not quoted on
ASX (including Performance rights
the +securities with an expiry
in section 2 if date of 30 June
9 applicable) 261,130 2019.
Performance rights
with an expiry
date of 30 June
290,476 2020.
Performance rights
with an expiry
929,155 of 30 June 2021.
Performance rights
with an expiry
2,936,379 of 30 June 2022.
----------- --------------------
10 Dividend policy n/a
(in the case of
a trust, distribution
policy) on the
increased capital
(interests)
---------------------------------
Part 2 -- Pro rata issue
11 Is security holder
approval required?
12 Is the issue renounceable
or non-renounceable?
13 Ratio in which
the +securities
will be offered
14 +Class of +securities
to which the offer
relates
15 +Record date to
determine entitlements
16 Will holdings
on different registers
(or subregisters)
be aggregated
for calculating
entitlements?
17 Policy for deciding
entitlements in
relation to fractions
18 Names of countries
in which the entity
has security holders
who will not be
sent new offer
documents
Note: Security
holders must be
told how their
entitlements are
to be dealt with.
Cross reference:
rule 7.7.
19 Closing date for
receipt of acceptances
or renunciations
20 Names of any underwriters
21 Amount of any
underwriting fee
or commission
22 Names of any brokers
to the issue
23 Fee or commission
payable to the
broker to the
issue
24 Amount of any
handling fee payable
to brokers who
lodge acceptances
or renunciations
on behalf of security
holders
25 If the issue is
contingent on
security holders'
approval, the
date of the meeting
26 Date entitlement
and acceptance
form and offer
documents will
be sent to persons
entitled
27 If the entity
has issued options,
and the terms
entitle option
holders to participate
on exercise, the
date on which
notices will be
sent to option
holders
28 Date rights trading
will begin (if
applicable)
29 Date rights trading
will end (if applicable)
30 How do security
holders sell their
entitlements in
full through a
broker?
31 How do security
holders sell part
of their entitlements
through a broker
and accept for
the balance?
32 How do security
holders dispose
of their entitlements
(except by sale
through a broker)?
33 +Issue date
Part 3 -- Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of +securities
(tick one)
(a) x +Securities described in Part 1 (Fully
Paid Ordinary Shares only)
(b) All other +securities
Example: restricted securities at the
end of the escrowed period, partly
paid securities that become fully paid,
employee incentive share securities
when restriction ends, securities issued
on expiry or conversion of convertible
securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you
are providing the information
or documents
35 If the +securities are +equity securities,
the names of the 20 largest holders
of the additional +securities, and
the number and percentage of additional
+securities held by those holders
36 If the +securities are +equity securities,
a distribution schedule of the additional
+securities setting out the number
of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional
+securities
Entities that have ticked box 34(b)
38 Number of +securities
for which +quotation
is sought
39 +Class of +securities
for which quotation
is sought
---------
40 Do the +securities
rank equally in
all respects from
the +issue date
with an existing
+class of quoted
+securities?
If the additional
+securities do
not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
41 Reason for request
for quotation
now
Example: In the
case of restricted
securities, end
of restriction
period
(if issued upon
conversion of
another +security,
clearly identify
that other +security)
---------
Number +Class
------- ---------
42 Number and +class
of all +securities
quoted on ASX
(including the
+securities in
clause 38)
------- ---------
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the (+) securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sign here: Pauline Carr Date: 3 July 2018
Company Secretary
== == == == ==
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
------------------------------------------------------------------------------
Step 1: Calculate "A", the base figure from
which the placement capacity is calculated
------------------------------------------------------------------------------
Insert number of fully
paid +ordinary securities
on issue 12 months
before the +issue date
or date of agreement
to issue 1,087,645,948
-------------------------------------------------------------- --------------
Add the following:
* Number of fully paid +ordinary securities issued in 3,234,303
that 12 month period under an exception in rule 7.2
Nil
* Number of fully paid +ordinary securities issued in Nil
that 12 month period with shareholder approval
* Number of partly paid +ordinary securities that
became fully paid in that 12 month period
Note:
* Include only ordinary securities here - other classes
of equity securities cannot be added
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------------------------- --------------
Subtract the number Nil
of fully paid +ordinary
securities cancelled
during that 12 month
period
-------------------------------------------------------------- --------------
"A" 1,090,880,251
-------------------------------------------------------------- --------------
Step 2: Calculate 15% of "A"
--------------------------------------------------------------------------------------------
"B" 0.15
[Note: this value cannot
be changed]
------------------------------------------------------------- -----------------------------
Multiply "A" by 0.15 163,632,038
------------------------------------------------------------- -----------------------------
Step 3: Calculate "C", the amount of placement
capacity under rule 7.1 that has already
been used
--------------------------------------------------------------------------------------------
Insert number of +equity Nil
securities issued or
agreed to be issued
in that 12 month period
not counting those
issued:
* Under an exception in rule 7.2
* Under rule 7.1A
* With security holder approval under rule 7.1 or rule
7.4
Note:
* This applies to equity securities, unless
specifically excluded - not just ordinary securities
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------------------------- -----------------------------
"C" Nil
------------------------------------------------------------- -----------------------------
Step 4: Subtract "C" from ["A" x "B"] to
calculate remaining placement capacity under
rule 7.1
--------------------------------------------------------------------------------------------
"A" x 0.15
Note: number must be
same as shown in Step
2 163,632,038
------------------------------------------------------------- -----------------------------
Subtract "C" Nil
Note: number must be
same as shown in Step
3
------------------------------------------------------------- -----------------------------
Total ["A" x 0.15] 163,632,038
- "C" Note: this is the remaining
placement capacity
under rule 7.1
------------------------------------------------------------- -----------------------------
Part 2
Rule 7.1A - Additional placement capacity
for eligible entities
-----------------------------------------------------------------------------------------
Step 1: Calculate "A", the base figure from
which the placement capacity is calculated
-----------------------------------------------------------------------------------------
"A"
Note: number must be
same as shown in Step
1 of Part 1 1,090,880,251
-------------------------------------------------------------- -------------------------
Step 2: Calculate 10% of "A"
-----------------------------------------------------------------------------------------
"D" 0.10
Note: this value cannot
be changed
-------------------------------------------------------------- -------------------------
Multiply "A" by 0.10 109,088,025
-------------------------------------------------------------- -------------------------
Step 3: Calculate "E", the amount of placement
capacity under rule 7.1A that has already
been used
-----------------------------------------------------------------------------------------
Insert number of +equity Nil
securities issued or
agreed to be issued
in that 12 month period
under rule 7.1A
Notes:
* This applies to equity securities - not just ordinary
securities
* Include here - if applicable - the securities the
subject of the Appendix 3B to which this form is
annexed
* Do not include equity securities issued under rule
7.1 (they must be dealt with in Part 1), or for which
specific security holder approval has been obtained
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------------------------- -------------------------
"E" Nil
-------------------------------------------------------------- -------------------------
Step 4: Subtract "E" from ["A" x "D"] to
calculate remaining placement capacity under
rule 7.1A
-------------------------------------------------------
"A" x 0.10
Note: number must be
same as shown in Step
2 109,088,025
------------------------ -----------------------------
Subtract "E" Nil
Note: number must be
same as shown in Step
3
------------------------ -----------------------------
Total ["A" x 0.10] 109,088,025
- "E" Note: this is the remaining
placement capacity
under rule 7.1A
------------------------ -----------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
IOEUGUQAMUPRUAC
(END) Dow Jones Newswires
July 04, 2018 02:00 ET (06:00 GMT)
1 Year Wolf Minerals Chart |
1 Month Wolf Minerals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
